ACETAdicet Bio Inc
$7.26
$0.89
(10.92%)
Closed $7.26
$0.0282
(0.39%)
After Hours
Reported EarningsMay 13
Mkt Cap$67.87M
Vol86,582.00
Fundamentals
Mkt Cap
$67.87M
Volume
-
52W High
$17.44
52W Low
$6.01
PE Ratio
-0.48
Avg. Volume
114,233.79
EPS (Annual)
-$16.95
Rev/Employee
$0.00
Earnings
May 13
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.
Zacks
Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 319.6% in Adicet Bio (ACET). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that...
Business Wire
Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial...
Business Wire
Johnson & Johnson Sells 341,693 Shares of Adicet Bio, Inc. $ACET
Johnson & Johnson lessened its stake in Adicet Bio, Inc. (NASDAQ:ACET - Free Report) by 93.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,779 shares of the company's stock after selling 341,693 shares during the quart...
MarketBeat
Adicet Bio (ACET) Expected to Announce Quarterly Earnings on Tuesday
Adicet Bio (NASDAQ:ACET) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
MarketBeat
Adicet Bio, Inc. (NASDAQ:ACET) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eight brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold ra...
MarketBeat
Adicet Bio (NASDAQ:ACET) Stock Passes Below Two Hundred Day Moving Average - Here's Why
Adicet Bio (NASDAQ:ACET) Stock Price Crosses Below 200-Day Moving Average - Time to Sell...
MarketBeat
Ra Capital Management, L.P. Buys 74,751 Shares of Adicet Bio (NASDAQ:ACET) Stock
Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) major shareholder Ra Capital Management, L.P. purchased 74,751 shares of the business's stock in a transaction on Friday, February 20th. The shares were acquired at an average price of $7.27 per share, with a total value of $543,439.77. Following the...
MarketBeat
Adicet Bio (NASDAQ:ACET) Major Shareholder Purchases $535,472.28 in Stock
Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) major shareholder Ra Capital Management, L.P. purchased 74,268 shares of the company's stock in a transaction on Thursday, February 19th. The shares were bought at an average price of $7.21 per share, with a total value of $535,472.28. Following the...
MarketBeat
<
1
2
...
>